Back to search

Peptide record

TPDB13630

Antibacterial Anticancer Toxicity standard
32 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB13630
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 32-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
IICRKPIICRKPIICRKPIICRKPIICRKPII
Physicochemical Analysis
C172H314N52O33S5
ANDEQGHLMFSTWYV
I
3799.01
11.03
10
0
12
+10
6.33
0.516
146.25
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
250
6.58
5
Residue Composition
number
0
A
5
R
0
N
0
D
5
C
0
E
0
Q
0
G
0
H
12
I
0
L
5
K
0
M
0
F
5
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 5 N: 0 D: 0 C: 5 E: 0 Q: 0 G: 0 H: 0 I: 12 L: 0 K: 5 M: 0 F: 0 P: 5 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
32
C172H314N52O33S5
3799.01
11.03
+10
6.33
0.516
Evidence Records 2 records
Evidence 1 Activity

Activity

0% Hemolysis
Toxicity
128 µM
Hemolytic Cytotoxic
0% Hemolysis | 128 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Rational Avoidance of Protease Cleavage Sites and Symmetrical End-Tagging Significantly Enhances the Stability and Therapeutic Potential of Antimicrobial Peptides | J Med Chem | 2020
Evidence 2 Activity

Activity

0% Killing
Toxicity
128 µM
Cytotoxic
0% Killing | 128 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Rational Avoidance of Protease Cleavage Sites and Symmetrical End-Tagging Significantly Enhances the Stability and Therapeutic Potential of Antimicrobial Peptides | J Med Chem | 2020